Business Description
Founded in 1915 and based in Valby, Denmark, H. Lundbeck A/S is a global pharmaceutical company focused entirely on brain diseases, developing and selling treatments for conditions such as depression, schizophrenia, epilepsy, migraine, and Parkinson's disease. The company markets a broad portfolio of established medicines across Europe, the United States, and other markets, while also advancing a pipeline of new treatments in various stages of clinical testing. Lundbeck also works with external partners, including a collaboration with Contera Pharma to explore a newer class of medicines for serious neurological conditions.
